Note Agreements
All Business Industries
PUMA BIOTECHNOLOGY, INC. (86) | Note Agreements (4)
- Fourth Amendment to Note Purchase Agreement, dated November29, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 2, 2023)
- Second Amendment to Note Purchase Agreement, dated May 18, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 2, 2023)
- Third Amendment to Note Purchase Agreement, dated September 16, 2022, by and between the Company and Athyrium Opportunities IV Co-Invest 1 LP, as Administrative Agent (Filed With SEC on November 3, 2022)
- First Amendment to Note Purchase Agreement, dated February 8, 2022, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 3, 2022)